GSK Takes Cue From Schering Patient Assistance Program, Seeks Opinion From OIG
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS Office of Inspector General will decide whether GlaxoSmithKline can donate medicines to Part D-enrolled patients.